BNP Paribas Financial Markets
FOLD

BNP Paribas Financial Markets’s Amicus Therapeutics FOLD Stock Holding History

BNP Paribas Financial Markets’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27M Sell
1,864,602
-387,108
-17% -$5.55M 0.01% 979
2025
Q4 		$32.1M Buy
2,251,710
+434,700
+24% +$4.27M 0.01% 916
2025
Q3 		$14.3M Buy
1,817,010
+566,641
+45% +$4.03M 0.01% 1306
2025
Q2 		$7.16M Buy
1,250,369
+747,461
+149% +$4.82M ﹤0.01% 1648
2025
Q1 		$4.1M Buy
502,908
+18,348
+4% +$170K ﹤0.01% 1936
2024
Q4 		$4.56M Sell
484,560
-81,416
-14% -$846K ﹤0.01% 1839
2024
Q3 		$6.04M Buy
565,976
+225,222
+66% +$2.45M ﹤0.01% 1399
2024
Q2 		$3.38M Sell
340,754
-247,881
-42% -$2.54M ﹤0.01% 1610
2024
Q1 		$6.93M Sell
588,635
-334,410
-36% -$4.28M 0.01% 1256
2023
Q4 		$13.1M Buy
923,045
+536,480
+139% +$6.09M 0.01% 904
2023
Q3 		$4.7M Buy
386,565
+224,870
+139% +$2.9M 0.01% 1316
2023
Q2 		$2.03M Sell
161,695
-122,086
-43% -$1.45M ﹤0.01% 1744
2023
Q1 		$3.15M Buy
283,781
+142,974
+102% +$1.76M ﹤0.01% 1537
2022
Q4 		$1.72M Sell
140,807
-210,939
-60% -$2.37M ﹤0.01% 1846
2022
Q3 		$3.67M Buy
351,746
+8,094
+2% +$90.2K 0.01% 1533
2022
Q2 		$3.69M Sell
343,652
-217,922
-39% -$1.79M 0.01% 1390
2022
Q1 		$5.32M Sell
561,574
-69,751
-11% -$654K 0.01% 1271
2021
Q4 		$7.29M Buy
631,325
+45,272
+8% +$505K 0.01% 1145
2021
Q3 		$5.6M Sell
586,053
-168,988
-22% -$1.73M 0.01% 1237
2021
Q2 		$7.28M Sell
755,041
-24,282
-3% -$237K 0.01% 1110
2021
Q1 		$7.7M Buy
779,323
+208,978
+37% +$3.23M 0.01% 945
2020
Q4 		$13.2M Buy
570,345
+191,503
+51% +$3.92M 0.02% 670
2020
Q3 		$5.35M Buy
378,842
+349,197
+1,178% +$5.09M 0.01% 1055
2020
Q2 		$447K Sell
29,645
-110,546
-79% -$1.35M ﹤0.01% 2146
2020
Q1 		$1.3M Buy
140,191
+102,177
+269% +$971K ﹤0.01% 1744
2019
Q4 		$370K Sell
38,014
-7,352
-16% -$67.3K ﹤0.01% 2647
2019
Q3 		$364K Buy
45,366
+19,179
+73% +$208K ﹤0.01% 2380
2019
Q2 		$327K Sell
26,187
-18,040
-41% -$229K ﹤0.01% 2288
2019
Q1 		$601K Buy
44,227
+39,835
+907% +$487K ﹤0.01% 1986
2018
Q4 		$42.1K Sell
4,392
-6,443
-59% -$70.8K ﹤0.01% 2799
2018
Q3 		$131K Buy
10,835
+866
+9% +$12.1K ﹤0.01% 2604
2018
Q2 		$156K Sell
9,969
-29,841
-75% -$451K ﹤0.01% 2566
2018
Q1 		$599K Buy
39,810
+4,923
+14% +$74.9K ﹤0.01% 2080
2017
Q4 		$502K Buy
34,887
+15,530
+80% +$213K ﹤0.01% 2473
2017
Q3 		$292K Sell
19,357
-48,655
-72% -$644K ﹤0.01% 2268
2017
Q2 		$685K Buy
68,012
+66,209
+3,672% +$533K ﹤0.01% 1735
2017
Q1 		$12.9K Sell
1,803
-1,816
-50% -$11.5K ﹤0.01% 3133
2016
Q4 		$18K Sell
3,619
-7,140
-66% -$49.4K ﹤0.01% 3231
2016
Q3 		$79.6K Buy
10,759
+5,809
+117% +$39.2K ﹤0.01% 2211
2016
Q2 		$27K Buy
+4,950
New +$34.6K ﹤0.01% 2478
2016
Q1 		– Sell
-26,520
Closed -$257K – 2815
2015
Q4 		$257K Buy
26,520
+2,883
+12% +$26K ﹤0.01% 1760
2015
Q3 		$331K Buy
23,637
+15,615
+195% +$245K ﹤0.01% 1617
2015
Q2 		$114K Buy
+8,022
New +$96.4K ﹤0.01% 2020
2014
Q3 		– Sell
-32
Closed -$107 – 4154
2014
Q2 		$107 Buy
32
+27
+540% +$63 ﹤0.01% 3754
2014
Q1 		$11 Sell
5
-389
-99% -$973 ﹤0.01% 3357
2013
Q4 		$926 Buy
+394
New +$865 ﹤0.01% 3845
2013
Q3 		– Sell
-13,374
Closed -$31.2K – 2621
2013
Q2 		$31.2K Buy
+13,374
New +$41.1K ﹤0.01% 2703

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

BNP Paribas Financial Markets's FOLD Position: Q1 2026 in Review

BNP Paribas Financial Markets reduced its Amicus Therapeutics (FOLD) stake by 17% in Q1 2026, selling an estimated $5.55M and leaving 1,864,602 shares worth $27M. The position accounts for 0.01% of the portfolio, ranked #979.

BNP Paribas Financial Markets first reported a position in FOLD in Q2 2013 and has held it in 47 quarters since. The position peaked at $32.1M in Q4 2025. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • BNP Paribas Financial Markets held 1,864,602 shares of Amicus Therapeutics worth $27M as of Q1 2026.
  • BNP Paribas Financial Markets sold 387,108 Amicus Therapeutics shares in Q1 2026, an estimated $5.55M.
  • Amicus Therapeutics made up 0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #979 holding.
  • BNP Paribas Financial Markets first reported a position in Amicus Therapeutics in Q2 2013 and has held it in 47 quarters since.
  • BNP Paribas Financial Markets's Amicus Therapeutics position peaked at $32.1M in Q4 2025.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.